[ESPR] QoQ Quarter Result on 31-Mar-2019 [#Q1]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
08-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- 245.54%
YoY- 289.42%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 982 981 982 145,419 184,474 0 0 -
PBT -61,946 -68,377 -54,221 87,379 -60,039 -49,911 -45,730 22.35%
Tax 5,165 5,383 0 0 -74 0 0 -
NP -61,946 -68,377 -54,221 87,379 -60,039 -49,911 -45,730 22.35%
Tax Rate - - - 0.00% - - - -
Total Cost 62,928 69,358 55,203 58,040 244,513 49,911 45,730 23.64%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin -6,308.15 -6,970.13 -5,521.49 60.09 -32.55 0.00 0.00 -
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
EPS -2.26 -2.52 -2.01 3.26 -2.24 -1.86 -1.71 20.37%
EPS Diluted -2.26 -2.52 -2.01 3.07 -2.24 -1.86 -1.71 20.37%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.